Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Receivables: 2010-2025

Historic Receivables for Vericel (VCEL) over the last 13 years, with Sep 2025 value amounting to $60.4 million.

  • Vericel's Receivables rose 24.64% to $60.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $239.0 million, marking a year-over-year increase of 16.71%. This contributed to the annual value of $61.4 million for FY2024, which is 5.17% up from last year.
  • As of Q3 2025, Vericel's Receivables stood at $60.4 million, which was down 6.01% from $64.3 million recorded in Q2 2025.
  • In the past 5 years, Vericel's Receivables ranged from a high of $64.3 million in Q2 2025 and a low of $28.9 million during Q3 2021.
  • Over the past 3 years, Vericel's median Receivables value was $49.9 million (recorded in 2024), while the average stood at $50.9 million.
  • Data for Vericel's Receivables shows a peak YoY soared of 34.15% (in 2021) over the last 5 years.
  • Over the past 5 years, Vericel's Receivables (Quarterly) stood at $37.4 million in 2021, then increased by 24.31% to $46.5 million in 2022, then grew by 25.39% to $58.4 million in 2023, then increased by 5.17% to $61.4 million in 2024, then grew by 24.64% to $60.4 million in 2025.
  • Its Receivables was $60.4 million in Q3 2025, compared to $64.3 million in Q2 2025 and $52.9 million in Q1 2025.